Pharmacoeconomic analysis of use the oral hypoglycemic agents in patients with type 2 diabetes mellitus according to a real clinical practice

• Autori principali: T. I. Ionova (Autore), T. P. Nikitina (Autore), A. Y. Rodionov (Autore), K. A. Kurbatova (Autore)
• Natura: Libro
• Pubblicazione: Izdatelstvo OKI, 2018-05-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

We aimed to conduct cost-utility analysis of two different regimens of the oral hypoglycemic therapy in 2 type diabetes mellitus (DM2). Methods. In the whole, 229 patients with DM2, receiving vildagliptin add-on to metformin (group 1) or sulphonylureas add-on to metformin (group 2) were enrolled in...